2 Potential Game Changers for Repros Therapeutics
After it was almost kicked off the Nasdaq in 2010, there was nowhere to go but up for Repros Therapeutics Inc. (Nasdaq: RPRX). Currently, the stock is trading more than 1,400% above its 52-week low of $0.36 per share (partially fueled by a reverse stock split back in October). And thanks to a better-than-expected earnings report, the Texas company shot 10% higher on April 14… [READ THE REST]
Written for Investment U.
AlexMoschina.com 